- Differential Diagnosis
Drug Information for FUROSEMIDEINJECTION, USP40 mg/mL (10 mg/mL) (McKesson Packaging Services Business unit of McKesson Corporation): INDICATIONS AND USAGE
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- HOW SUPPLIED
- PACKAGE DISPLAY PANEL
- External Links Related to FUROSEMIDEINJECTION, USP40 mg/mL (10 mg/mL) (McKesson Packaging Services Business unit of McKesson Corporation)
Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.
Edema: Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired.
Furosemide is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of furosemide is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema.
If gastrointestinal absorption is impaired or oral medication is not practical for any reason, furosemide is indicated by the intravenous or intramuscular route. Parenteral use should be replaced with oral furosemide as soon as practical.
- Drug Information Provided by National Library of Medicine (NLM).